Canada· CA-DIN-02243180

AA-FENO-MICRO

A fenofibrate product containing fenofibrate, registered in Canada by AA PHARMA INC. The same ATC class is registered in 15 of our 19 countries.

ATC C10AB05

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedAA-FENO-MICROATCC10AB05REGISTER NO.CA-DIN-02243180PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Fenofibrate is registered in 15 of 19 countries.

Countries holding a registration under ATC C10AB05 (fenofibrate), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 10 of them publish a price we can compare per daily dose

Fenofibrate · ATC C10AB05

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fenofibrate costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.22 in Spain to $1.30 in United States — a ×5.8 gap.

  • 5 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Fenofibrate · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • US United States$1.30 (acquisition cost)
  • CH Switzerland$0.75
  • IT Italy$0.35
  • FR France$0.24
  • ES Spain$0.22
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
FENOFIBRATE
Manufacturer
AA PHARMA INC
Country
Canada (CA)
ATC code
C10AB05
ATC class
Fenofibrate
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

268 interactions on record for fenofibrate.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fenofibrate · interactions on record

268 records

  • 10 severe
  • 75 moderate
  • 183 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • SimvastatinC10AA01severe
  • RosuvastatinC10AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fenofibrate in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fenofibrate products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Fenolip Retard, Lipcor
  • Belgium · Fenofibraat Eg, Fenofibrate Ab
  • Bulgaria · Липантил, Липантил Супра
  • Cyprus · Lipidil Nt
  • Czechia · Fenofix, Fortilip
  • Germany · Cil, Elipsia
  • Estonia · Lipanthyl
  • Spain · Fenofibrate Teva, Fenofibrato Aurovitas
  • Finland · Lipanthyl Penta
  • France · Fegenor, Fenofibrate Almus
  • United Kingdom (Northern Ireland) · Fenofibrate, Fenofibrate Accord Uk
  • Greece · Fenobrat, Lipidil Nt
  • Croatia · Fenolip, Tricor
  • Hungary · Fenobrat, Fenoswiss
  • Ireland · Lipantil Micro, Lipantil Supra
  • Italy · Fenofibrato Aurobindo, Fenofibrato Eg
  • Lithuania · Lipanthyl
  • Luxembourg · Fenofibraat Eg, Fenogal Lidose
  • Latvia · Lipanthyl
  • Malta · Lipantil Supra
  • Netherlands · Fenogal
  • Norway · Thylip
  • Poland · Biofibrat, Fenardin
  • Portugal · Catalip, Catalip Micronizado
  • Romania · Fenofibrat Terapia, Lipanthyl Supra
  • Sweden · Lipanthyl, Thylip
  • Slovenia · Katalip
  • Slovakia · Fenofibrate Teva, Fenofix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5a610f07-a08e-4c6d-b6d2-8b29aa4a8816
GET /v1/drugs/5a610f07-a08e-4c6d-b6d2-8b29aa4a8816?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02243180",
  "form": "CAPSULE",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "C10AB05",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "67060",
  "strengths": [
    "67 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "FENOFIBRATE"
  ],
  "product_categorization": null
}

See everything about fenofibrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.